Leaflet APO-GO 10mg / ml solution for injection / infusion

Indicated for: Parkinson's disease

Route of administration: injectable / infusion

Substance: apomorphine (antiparkinsonian agent)

ATC: N04BC07 (Nervous system | Dopaminergic agents | Dopamine agonists)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse
Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression
Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol
Avoid alcohol

Avoid alcohol during treatment.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Apomorphine is a dopamine receptor agonist used in the treatment of Parkinson's disease, particularly for managing motor block episodes (off episodes). It works by directly stimulating dopamine receptors in the brain, alleviating motor symptoms such as rigidity, tremor, and bradykinesia.

Apomorphine is administered as subcutaneous injections or through continuous infusion pumps, depending on the patient's needs. It is often used as a rescue therapy for patients who do not respond adequately to oral treatments.

Common side effects include nausea, vomiting, orthostatic hypotension, and drowsiness. In rare cases, allergic reactions or compulsive behaviors may occur. It is important for treatment to be initiated under strict medical supervision.

Apomorphine is a valuable therapeutic option for patients with Parkinson's disease, helping to improve quality of life by reducing motor block episodes.

General data about APO-GO 10mg / ml

  • Substance: apomorphine
  • Date of latest medicines list: 01-10-2019
  • Product code: W66229001
  • Concentration: 10mg / ml
  • Pharmaceutical form: solution for injection / infusion
  • Quantity: 5
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: STADA ARZNEIMIITEL AG - GERMANIA (in timpul
  • Holder: STADA ARZNEIMITTEL AG - GERMANIA
  • Number: 12114/2019/01
  • Shelf life: 3 years-after packing for marketing; after the first opening-it is used immediately

Concentrations available for apomorphine

  • 10mg/ml
  • 2mg
  • 3mg
  • 5mg/ml